from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0218/-

LFCtreatmentdescriptionclass of inhibitor

-0.225

Amikacinug/mL Amikacintranslation

-0.628

Cap5-10ug/mL Capreomycintranslation

-1.047

Rox10-50 ug/mL Roxithromycintranslation

-1.380

SM2-5 ug/mL Streptomycintranslation

0.413

Tet5-10 ug/mL Tetracyclinetranslation

1.105

Rif0.2-5ug/mL Rifampicintranscription

-0.270

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.101

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.223

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.497

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.365

Clofazimine10-13 ug/mL Clofaziminerespiration

0.183

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.593

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.053

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.913

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.974

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.151

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.666

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.362

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.304

KCN5-20 ug/mL Potassium cyaniderespiration

-0.268

NaN30.2-2 mM Sodium aziderespiration

-0.426

Nigericin50 uM Nigericinrespiration

-0.267

TRC10-150 ug/mL Triclosanrespiration

0.504

TRZ10-25 ug/mL Thioridazinerespiration

-0.869

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.159

menadione6-10 ug/mL Menadionerespiration

0.071

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.298

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.158

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.390

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.404

NRP_1Non-replicating persistence stage 1dosRassociated

-0.314

Amp0.2mg/mL AmpicillincellWall

-0.449

Cephalexin20-100 ug/mL CephalexincellWall

-0.378

Cerulenin0.32-5 ug/mL CerulenincellWall

0.658

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.377

EMB10-20 ug/mL EthambutolcellWall

-1.165

Eta12-40 ug/mL EthionamidecellWall

-0.404

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.451

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.034

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.062

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.528

BZA0.12 mg/mL BenzamidearomaticAmides

0.975

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.620

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.331

H2O24 mM hydrogen peroxideDNAdamaging

-0.182

Levo10 ug/mL LevofloxacinDNAdamaging

0.868

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.573

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.516

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.370

UVUV-irradiationDNAdamaging

-0.619

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.099

Antimycin12.5-50 ug/mL Antimycin A?

-0.556

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.292

PA_110-50 ug/mL Antitubercular compound PA-1?

0.036

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.323

PA8240.2-2 ug/mL PA-824?

-0.141

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.293

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.372

Verapamil50 uM Verapamil?

-0.042

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.441

methoxatin10-20 ug/mL Methoxatin?